Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease
Article Date
October 1, 2023
This article is featured on another website.
Go to article
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
April 17, 2026
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…
April 17, 2026
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…